Alphatec Holdings (ATEC) 7.12 $ATEC Alphatec Ho
Post# of 273254
Alphatec Holdings Announces Company Updates
GlobeNewswire - Thu Sep 15, 3:30PM CDT
Company Names Chairman Leslie H. Cross as Interim CEO
ATEC: 7.12 (+0.79)
Alphatec Holdings Completes Sale of International Business to Globus Medical
GlobeNewswire - Thu Sep 01, 3:22PM CDT
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, today announced the completion of the previously announced sale of its international operations and distribution channel to Globus Medical (NYSE:GMED), a leading musculoskeletal implant manufacturer.
ATEC: 7.12 (+0.79), GMED: 22.46 (+0.25)
Globus Medical Completes Acquisition of Alphatec's International Business
GlobeNewswire - Thu Sep 01, 3:15PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has successfully completed the previously announced acquisition of the international operations and distribution channels of Alphatec Holdings, Inc., a publicly traded medical devices company (Nasdaq:ATEC).
ATEC: 7.12 (+0.79), GMED: 22.46 (+0.25)
Alphatec Holdings Announces One-for-Twelve Reverse Stock Split
GlobeNewswire - Wed Aug 24, 10:59AM CDT
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, today announced the effectiveness of a one-for-twelve reverse stock split of its common stock. The reverse stock split will take effect at 5:00 pm Eastern Time on August 24, 2016 and the Company's common stock will open for trading on The NASDAQ Global Select Market on August 25, 2016 on a post-split basis.
ATEC: 7.12 (+0.79)
AMETEK (AME) Posts In Line Q1 Earnings, Misses Revenues
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 12:16PM CDT
AMETEK Inc.'s (AME) first quarter 2016 earnings of 57 cents per share matched the Zacks Consensus Estimate.
ATEC: 7.12 (+0.79), AME: 47.33 (+0.55), EW: 119.17 (+1.75), CVRS: 1.17 (unch)
IDEXX Beats Q4 Earnings and Revenues on Strong US Sales
Zacks Equity Research - Zacks Investment Research - Mon Feb 01, 8:40AM CST
IDEXX Laboratories Inc. (IDXX) reported fourth-quarter 2015 adjusted earnings per share (EPS) of 48 cents.
ATEC: 7.12 (+0.79), ABMD: 126.90 (+1.80), IDXX: 112.07 (+0.24), ARAY: 5.80 (+0.12)
EU5 Spinal Surgery Market Outlook to 2021 - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices.
M2 - Fri Jan 15, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/drkdtm/eu5_spinal) has announced the addition of the "EU5 Spinal Surgery Market Outlook to 2021" report to their offering. "EU5 Spinal Surgery Market Outlook to 2021", provides key market data on the EU5 Spinal Surgery market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Spinal Surgery market. - Global corporate-level profiles of key companies operating within the EU5 Spinal Surgery market. - Key players covered include Medtronic, Inc., DePuy Companies, Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Orthofix International N.V., Zimmer Holdings, Inc., Biomet, Inc., Alphatec Holdings, Inc. and K2M, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Spinal Surgery Market, EU5 4 Spinal Surgery Market, France 5 Spinal Surgery Market, Germany 6 Spinal Surgery Market, Italy 7 Spinal Surgery Market, Spain 8 Spinal Surgery Market, United Kingdom 9 Overview of Key Companies in EU5 Spinal Surgery Market - Medtronic plc - DePuy Companies - Stryker Corporation - Zimmer Biomet Holdings, Inc. - B. Braun Melsungen AG - Biomet, Inc. - Alphatec Holdings, Inc. - NuVasive, Inc. - LDR Holding Corporation - Integra LifeSciences Holdings Corporation - Globus Medical, Inc. - MEDACTA Interna For more information visit http://www.researchandmarkets.com/research/drkdtm/eu5_spinal
ZMH: 113.56 (+0.29), ATEC: 7.12 (+0.79), ZBH: 127.19 (+2.40), LDRH: 36.98 (-0.02), MDT: 87.14 (+0.78), IARTV: 65.00 (-37.45), GMED: 22.46 (+0.25), OFIX: 43.58 (-0.59), NUVA: 67.00 (+0.11), SYK: 116.44 (+1.84)
North America Spinal Surgery Market Outlook to 2021 - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices
M2 - Fri Jan 15, 3:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/ngvq6j/north_america) has announced the addition of the "North America Spinal Surgery Market Outlook to 2021" report to their offering. "North America Spinal Surgery Market Outlook to 2021", provides key market data on the North America Spinal Surgery market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Spinal Surgery market. - Global corporate-level profiles of key companies operating within the North America Spinal Surgery market. - Key players covered include Medtronic, Inc., DePuy Companies, Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Orthofix International N.V., Zimmer Holdings, Inc., Biomet, Inc., Alphatec Holdings, Inc. and K2M, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Spinal Surgery Market, North America 4 Spinal Surgery Market, Canada 5 Spinal Surgery Market, Mexico 6 Spinal Surgery Market, United States 7 Overview of Key Companies in North America Spinal Surgery Market 8 Spinal Surgery Market Pipeline Products 9 Recent Developments 10 Appendix Companies Mentioned - Medtronic plc - DePuy Companies - Stryker Corporation - Zimmer Biomet Holdings, Inc. - LDR Holding Corporation - NuVasive, Inc. - Globus Medical, Inc. - Biomet, Inc. - Alphatec Holdings, Inc. - K2M, Inc. - Integra LifeSciences Holdings Corporation For more information visit http://www.researchandmarkets.com/research/ng...th_america
ZMH: 113.56 (+0.29), ATEC: 7.12 (+0.79), ZBH: 127.19 (+2.40), LDRH: 36.98 (-0.02), MDT: 87.14 (+0.78), IARTV: 65.00 (-37.45), GMED: 22.46 (+0.25), OFIX: 43.58 (-0.59), NUVA: 67.00 (+0.11), SYK: 116.44 (+1.84)
Thermo Fisher to Buy Affymetrix for $1.3B; Boost Biosciences
Zacks Equity Research - Zacks Investment Research - Mon Jan 11, 1:35PM CST
Thermo Fisher (TMO) decides to buy Affymetrix Inc. (AFFX) for a value worth $1.3 billion.
ATEC: 7.12 (+0.79), ABMD: 126.90 (+1.80), TMO: 155.42 (+3.80), AFFX: 14.01 (+0.02)
United States Spinal Surgery Market Outlook to 2021
M2 - Fri Jan 08, 9:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/pnh288/united_states) has announced the addition of the "United States Spinal Surgery Market Outlook to 2021" report to their offering. "United States Spinal Surgery Market Outlook to 2021", provides key market data on the United States Spinal Surgery market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Spinal Fusion, Spinal Non-Fusion, Vertebral Body Replacement Systems, Minimal Invasive Spinal Devices and Vertebral Compression Fracture Repair Devices. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. The data in the report is derived from dynamic market forecast models. We use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Scope - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Spinal Surgery market. - Global corporate-level profiles of key companies operating within the United States Spinal Surgery market. - Key players covered include Medtronic, Inc., DePuy Companies, Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Orthofix International N.V., Zimmer Holdings, Inc., Biomet, Inc., Alphatec Holdings, Inc. and K2M, Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Spinal Surgery Market, United States 4 Overview of Key Companies in United States, Spinal Surgery Market 5 Spinal Surgery Market Pipeline Products 6 Financial Deals Landscape 7 Appendix Companies Mentioned - Medtronic plc - DePuy Companies - NuVasive, Inc. - Stryker Corporation - Globus Medical, Inc. - Zimmer Biomet Holdings, Inc. - LDR Holding Corporation - Alphatec Holdings, Inc. - K2M, Inc. For more information visit http://www.researchandmarkets.com/research/pn...ted_states
ZMH: 113.56 (+0.29), ATEC: 7.12 (+0.79), ZBH: 127.19 (+2.40), LDRH: 36.98 (-0.02), MDT: 87.14 (+0.78), GMED: 22.46 (+0.25), OFIX: 43.58 (-0.59), NUVA: 67.00 (+0.11), SYK: 116.44 (+1.84)
New Strong Buy Stocks for January 5th
Zacks Equity Research - Zacks Investment Research - Tue Jan 05, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
ATEC: 7.12 (+0.79), ANW: 10.06 (+0.41), AFAM: 36.61 (+0.61), ABAX: 51.84 (+0.36), ACIW: 18.51 (+0.21)
BUYINS.NET: ATEC, OSIR, DBV, SMCI, CXO, NMM Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 09, 8:56AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Alphatec Holdings Inc (NASDAQ:ATEC), Osiris Therapeutics Inc (NASDAQ:OSIR), Doubleview Capital Corp (NYSE BV), Super Micro Computer Inc (NASDAQ:SMCI), Concho Resources Inc (NYSE:CXO), Navios Maritime Partners LP (NYSE:NMM) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CXO: 128.31 (+5.54), ATEC: 7.12 (+0.79), SMCI: 22.74 (+0.62), NMM: 1.38 (+0.02), OSIR: 4.89 (-0.08), DBV: 24.78 (+0.09)
Alphatec Spine to Present at 27th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Tue Nov 17, 6:23PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company's executives, Jim Corbett, President and Chief Executive Officer, and Mike O'Neill, Chief Financial Officer, will participate in the 2015 Piper Jaffray Healthcare Conference. Mr. Corbett will provide a corporate overview of the Company's strategy during the presentation session of the Piper Jaffray Healthcare Conference on December 2, 2015 at 12:00 p.m. Eastern Time at the New York Palace Hotel in New York, NY.
ATEC: 7.12 (+0.79)
Alphatec reports 3Q loss
Automated Insights - Tue Nov 03, 5:51PM CST
CARLSBAD, Calif. (AP) _ Alphatec Holdings Inc. (ATEC) on Tuesday reported a loss of $160.3 million in its third quarter.
ATEC: 7.12 (+0.79)
Alphatec Holdings Announces Third Quarter 2015 Revenue and Financial Results
GlobeNewswire - Tue Nov 03, 3:42PM CST
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for the third quarter ended September 30, 2015.
ATEC: 7.12 (+0.79)
Alphatec Spine reports departure of board member James R. Glynn
M2 - Mon Nov 02, 8:56AM CST
Medical device company Alphatec Holdings (NasdaqGS:ATEC) stated on Friday that James R. Glynn plans to step down as a member of the board of directors and audit committee chairman from 2 November 2015.
ATEC: 7.12 (+0.79)
Alphatec Spine Announces Retirement of James R. Glynn From Its Board of Directors; Donald A. Williams Appointed Audit Committee Chairman
GlobeNewswire - Fri Oct 30, 8:05AM CDT
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that James R. Glynn is retiring as a member of the board of directors and Audit Committee Chairman, effective November 2, 2015. Alphatec Spine's board of directors has appointed Donald A. Williams, an independent director of Alphatec's board of directors and current member of the Audit Committee, as the Chairman of the Audit Committee, effective November 2, 2015.
ATEC: 7.12 (+0.79)
Leading 200 Global Medical Devices/Technology/Supplies Company Analysis 2015 - News, Financial/Non-Financial Information, and Stock Market Analysis
M2 - Wed Oct 21, 2:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5th588/global_most) has announced the addition of the "Global Most International Medical Devices/Technology/Supplies 200 " report to their offering. This newly launched report identifies 200 Most International medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information, and stock market analysis. In today's rapidly changing business climate, understanding the regulatory and demographic environment of the medical industry is only part of the challenge. The real struggle for medical device companies is defining the right strategy, particularly with increasing consolidation, heightened regulation, and shifting market demands. Firms that are able to adapt quickly, taking advantage of the transformative nature of the industry, will become inherent market leaders. There are many companies in the medical devices/technology/supplies industry that have presence in many countries worldwide. Since last few years, these companies have established and expanded their presence in global markets. Such companies are dedicated to improving people's health throughout the world. These companies have global marketing and sales capabilities with a presence in many countries worldwide. Highlights - Leading 200 Most Global medical devices/technology/supplies companies covered - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Most Global medical devices/technology/supplies companies - International presence of Most Global medical devices/technology/supplies companies - Key R&D activities by Most Global medical devices/technology/supplies companies Key Topics Covered: nalysis Section: 1: Rankings of Most Global Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 12 Months: Leading 25 Most Global Medical Devices/Technology/Supplies Companies with Most Increases News Section: 3: Key News of Most Global Medical Devices/Technology/Supplies Companies for Year 2014-15 4: Key Alliances of Most Global Medical Devices/Technology/Supplies Companies 5: Research and Development Activities by Most Global Medical Devices/Technology/Supplies Companies 6: International Presence of Most Global Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Most Global Medical Devices/Technology/Supplies Companies Sample list of company names included in this industry report: - 3 D Matrix Ltd (Japan) - 3M Company (United States) - aap Implantate AG (Germany) - Abaxis Inc (United States) - Abcam Plc (United Kingdom) - Accuray Inc (United States) - Alphatec Holdings, Inc. (United States) - Ambu A/S (Denmark) - Amplifon SpA (Italy) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Baxter International Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Boston Scientific Corporation (United States) - Bruker Corporation (United States) - Carl Zeiss Meditec AG (Germany) - Cepheid (United States) - Cochlear Limited (Australia) - Coherent Incorporated (United States) - Draegerwerk AG & Co KGaA (Germany) - Fresenius Medical Care AG & Co. KGaA (Germany) - Hitachi High Technologies Corp (Japan) - Impedimed Limited (Australia) - Masimo Corporation (United States) - Nitto Denko (Japan) - Osim International Limited (Singapore) - Sonova Holding AG (Switzerland) - Stratec Biomedical AG (Germany) - Zimmer Holdings, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/5t...lobal_most
ZMH: 113.56 (+0.29), MMM: 179.59 (+1.99), ATEC: 7.12 (+0.79), MASI: 59.85 (+0.54), ARAY: 5.80 (+0.12), BSX: 23.73 (+0.42), ABAX: 51.84 (+0.36), BAX: 47.92 (+0.53), CPHD: 52.53 (+0.04), COHR: 110.50 (+3.55)